Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Trawick International GmbH Announces Strategic Partnership with Zurich Benelux to Bolster Student Insurance Offerings
-
Staffing 360 Solutions Receives Nasdaq Notification Related to Non-Timely Filing of its 2023 Form 10-K
-
Form 8.3 - ABRDN European Logistics Income Plc
-
Shifting Regulations and Emerging Threats Cause Nearly a Third of CISOs to Consider Leaving Their Roles
-
TMC & SGS Produce World-First Nickel Sulfate from Deep-Seafloor Polymetallic Nodules
-
Old National Bancorp Reports First Quarter 2024 Results
-
Xometry to Announce First Quarter 2024 Financial Results on May 9, 2024
-
Baker Hughes Awarded Significant Gas Technology Scope for Phase 3 of Saudi Arabia’s Master Gas System
-
Preferred Bank Reports Quarterly Results
-
TMC & SGS Produce World-First Nickel Sulfate from Deep-Seafloor Polymetallic Nodules
-
Altus Group Announces Winners of the 2024 ARGUS University Challenge
-
Parex Resources Announces Timing of Q1 2024 Results, Annual General Meeting, and Foothills Investor Presentation
-
Solid Power, Inc. Announces Timing of First Quarter 2024 Earnings Release and Conference Call
-
WEST MINING ANNOUNCES PRIVATE PLACEMENT
-
Dominion Lending Centres Inc. Announces First Quarter 2024 Earnings Release Date
-
Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market
-
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
-
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infecti
-
Big 5 Sporting Goods Corporation to Report Fiscal 2024 First Quarter Results on April 30, 2024
-
Crowdbotics Enters Collaboration with Microsoft to Accelerate App Development with CodeOps
-
Monarch Private Capital and Elawan Energy Announce Substantial Completion of Two Renewable Energy Projects
-
Vital Battery Metals Announces 2024 Exploration & Drilling Program on its Sting Copper Project
-
LifeMD to Participate in Upcoming Investor and Industry Conferences During May
-
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
-
SpecialtyVETPATH Taps Proscia For A Full Transformation Of Its Pathology Operations
-
Code42 to Showcase Insider Threat and Source Code Protection at RSA Conference
-
OncoC4 Announces FDA Clearance of IND Application for Novel SIGLEC 10 Immune Checkpoint Inhibitor ONC-841 for Solid Tumors
-
RTI Earns 2024 Great Place To Work Certification™ in the U.S. and Spain for the Sixth Consecutive Year
-
INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay
-
Panelite releases product lines for Peterbilt 589
-
Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
-
Launching Reach 2.0: Next-Gen Event Marketing Platform for Webinars and Field Marketing Events
-
Aemetis to Present to Institutional Investors at UBS, JP Morgan and Stifel Conferences to Review Recent Federal Approval of $200 Million of EB-5 Funding for SAF, Biogas, and CCS Projects
-
Coda Octopus Group Reports Sizable Sale of Echoscope PIPE® Sonars to Major Offshore Service Provider.
-
Energy and Water Development Corp. (EAWD) Appoints Bevilacqua PLLC as SEC and Capital Markets Counsel
-
Luckin Coffee to Announce First Quarter 2024 Financial Results on April 30, 2024
-
Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting
-
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
-
INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay
-
Clinical ink announces GlucoseReady™
-
PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
-
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
-
Monarch Private Capital and Elawan Energy Announce Substantial Completion of Two Renewable Energy Projects
-
G2 Spring 2024 Report: Huntress Claims Dominance in Endpoint and Managed Detection, Named Industry Leader
-
PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic
-
Tome Biosciences to Present Data on Programmable Genomic Integration Technologies at ASGCT
-
Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024
-
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
-
CEX.IO’s Mark Taylor, Global Head of Financial Crime to Join Panel Organized by C5
-
Arteris to Announce Financial Results for the First Quarter 2024 on Thursday, May 2, 2024

